Cited by 497Interstitial Lung Diseases and Idiopathic Pulmonary FibrosisTransplantation: Methods and OutcomesPulmonary Hypertension Research and Treatments

A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18

Prasse, Antje, Pechkovsky, Dmitri V., Toews, Galen B., Jungraithmayr, Wolfgang, Kollert, Florian, Goldmann, Torsten, Vollmer, Ekkehard, Müller-Quernheim, Joachim +1 more·2006·American Journal of Respiratory and Critical Care Medicine

Abstract

Rationale: Recently, models of macrophage activation have been revised. Macrophages stimulated with Th2 cytokines have been classified as alternatively activated. Objectives: This article examines the expression and regulation of CC chemokine ligand 18 (CCL18), a marker of alternative activation, by human alveolar macrophages (AMs). Methods: AM were obtained from bronchoalveolar lavage (BAL) fluid of patients with idiopathic pulmonary fibrosis, sarcoidosis, or hypersensitivity pneumonitis (n = 69) and healthy volunteers (n = 22). Expression of CCL18 was determined by quantitative reverse transcriptase–polymerase chain reaction, in situ hybridization, flow cytometry, and immunohistochemistry, respectively. Measurements and Main Results: Spontaneous CCL18 production by BAL-derived cells was markedly increased in patients with pulmonary fibrosis and correlated negatively with pulmonary function test parameters. CCL18 gene expression and protein production were up-regulated in normal AMs after Th2 cytokine stimulation and/or coculture with human lung fibroblasts. Native collagen significantly up-regulated CCL18 expression in normal AMs activated with Th2 cytokines via a mechanism mediated by β2-integrin/ scavenger receptor(s). Culture supernatants of AMs from patients with idiopathic pulmonary fibrosis increased collagen production by normal lung fibroblasts partly mediated via CCL18. Conclusions: Our findings suggest that AMs from patients with pulmonary fibrosis disclose a phenotype of alternative activation and might be a part of a positive feedback loop with lung fibroblasts perpetuating fibrotic processes.

Integrity signals

Registry

Crossref · 10.1164/rccm.200509-1518oc

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Prasse, A., Pechkovsky, D. V., Toews, G. B., Jungraithmayr, W., Kollert, F., Goldmann, T., Vollmer, E., Müller-Quernheim, J., & Zissel, G.
Affiliations
  • University of Michigan (US)
  • Departments of Pneumology and Thoracic Surgery, University Hospital, Freiburg; Division of Clinical and Experimental Pathology, Research Center, Borstel, Germany; and Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2006-04-01
Volume
173
Issue
7
Pages
781-792
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W2171849700
Cited by
497
References
57
Citations by year
2026: 20 · 2025: 25 · 2024: 37 · 2023: 38 · 2022: 33 · 2021: 28 · 2020: 27 · 2019: 21 · 2018: 22 · 2017: 26 · 2016: 32 · 2015: 18 · 2014: 20 · 2013: 33 · 2012: 27
FWCI
13.56
Type
journal article
Language
en
Open access
closed
Locations
  • American Journal of Respiratory and Critical Care Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Pulmonary Hypertension Research and Treatments
Keywords
CCL18, alveolar macrophages, lung fibroblasts, pulmonary fibrosis, alternative macrophage activation, Th2 cytokines, idiopathic pulmonary fibrosis, sarcoidosis, hypersensitivity pneumonitis, collagen synthesis, beta2 integrins, scavenger receptors, macrophage-fibroblast interaction, positive feedback loop
MeSH terms
Biopsy, Bronchoalveolar Lavage Fluid, Cell Line, Fibroblasts, Humans, Immunohistochemistry, Macrophage Activation, Pulmonary Fibrosis, RNA, Messenger, Gene Expression, Cytokines, Macrophages, Alveolar, In Situ Hybridization, Chemokines, CC, Reverse Transcriptase Polymerase Chain Reaction, Collagen Type I, In Vitro Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review